ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 33710348

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.

de Jonge MM and 18 others. J Natl Cancer Inst, 2021. Cited by 76 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study. Papers, record 33710348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33710348

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
2021
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
4.47
iCite
Revised in PubMed
2024-08-15
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Jonge MMMarthe M
2de Kroon CDCornelis D
3Jenner DJDenise J
4Oosting JJanhttps://orcid.org/0000-0001-8894-1742
5de Hullu JAJoanne A
6Mourits MJEMarian J Ehttps://orcid.org/0000-0003-2385-2639
7Gómez Garcia EBEncarna B
8Ausems MGEMMargreet G E M
9Margriet Collée JJ
10van Engelen KKlaartje

1 to 10 of 19Source PubMed

See all 19 authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Endometrial NeoplasmsMajor topic
Adult
BRCA1 Protein
BRCA2 Protein
Cohort Studies
Female
Genetic Predisposition to Disease
Germ Cells
Heterozygote
Humans
Mutation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in33,710,310BRCA1/2 and Endometrial Cancer Risk: Implications for Management.https://conductscience.org/library/papers/33710310PubMed
Comment in34,424,329RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.https://conductscience.org/library/papers/34424329PubMed

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,080,033Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.Mod Pathol2013https://conductscience.org/library/papers/23080033PubMed
231,492,746Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.Clin Cancer Res2019https://conductscience.org/library/papers/31492746PubMed
321,720,365Integrated genomic analyses of ovarian carcinoma.Nature2011https://conductscience.org/library/papers/21720365PubMed
422,691,381Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.Breast Cancer Res2012https://conductscience.org/library/papers/22691381PubMed
525,788,320Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.J Natl Cancer Inst2015https://conductscience.org/library/papers/25788320PubMed
624,882,434Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.Lancet Oncol2014https://conductscience.org/library/papers/24882434PubMed
723,562,522The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.Gynecol Oncol2013https://conductscience.org/library/papers/23562522PubMed
816,495,918Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.Br J Cancer2006https://conductscience.org/library/papers/16495918PubMed
927,139,150Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.Arch Pathol Lab Med2016https://conductscience.org/library/papers/27139150PubMed
1030,415,991Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression.Gynecol Oncol2019https://conductscience.org/library/papers/30415991PubMed

1 to 10 of 33

See all 33 references

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42,959,853A urothelial cell carcinoma in the abdominal cavity after salpingectomy for tubo-ovarian carcinoma risk reduction in a BRCA1 pathogenic variant carrier.Gynecol Oncol Rep2026https://conductscience.org/library/papers/42959853PubMed
42,433,835Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42433835PubMed
42,055,802Uterine serous carcinoma and germline genetic testing: patterns of referral, completion and pathogenic variant detection.J Med Genet2026https://conductscience.org/library/papers/42055802PubMed
41,947,901A rare case of uterine carcinosarcoma in a 21-year-old woman with hereditary breast and ovarian cancer syndrome: A case report.Oncol Lett2026https://conductscience.org/library/papers/41947901PubMed
41,883,871An intriguing journey into the hereditary syndromes predisposing to endometrial cancer: more than believed.Ther Adv Med Oncol2026https://conductscience.org/library/papers/41883871PubMed
41,683,729Hereditary Endometrial Cancer: Lynch Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions-A Comprehensive Review with Clinical and Laboratory Guidelines.Int J Mol Sci2026https://conductscience.org/library/papers/41683729PubMed
41,619,719BRCA1 and BRCA2 carriers: Perceptions of endometrial cancer risk.Gynecol Oncol2026https://conductscience.org/library/papers/41619719PubMed
41,612,487Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction.Isr J Health Policy Res2026https://conductscience.org/library/papers/41612487PubMed
41,455,088Prevalence of germline 113 cancer genes in healthy Indonesian hospital staff.Genes Genomics2026https://conductscience.org/library/papers/41455088PubMed
41,155,736Endometrial Carcinoma and Associated Secondary Neoplasia: The Role of Clinical Features, Pathology, and Comorbidities in a University-Affiliated Clinical Center from Western Romania.Medicina (Kaunas)2025https://conductscience.org/library/papers/41155736PubMed

1 to 10 of 53

See all 53 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
COL11A21,302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33710348

GET https://conductscience.org/api/papers/v1/33710348/references?page=2

API referenceFor AI assistants